Wysong, A., Somani, A. ., Ibrahim, . S., Cañueto, J. ., Fitzgerald, A. ., Siegel, J. ., Prasai, A., Goldberg, M., Farberg, A., Kasprzak, J. ., Brodland, D. ., Koyfman, S., & Arron, S. . (2024). Incorporating the 40-Gene Expression Profile (40-GEP) Test within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors. SKIN The Journal of Cutaneous Medicine, 8(1), s334. https://doi.org/10.25251/skin.8.supp.334